CCL2 and colitis: Research indicates that the serum exosomes lead to an upregulation of NLRP12 expression in intestinal epithelial cells, which inhibits the expression of chemokine MCP-1 and MIP-1α in these cells, alleviating DSS-induced colitis (Chen et al., 2020).